Deal Corner
May 01, 2011
QPS Holdings LLC acquired a controlling stake in Bioserve Clinical Research Private Limited now known as QPS Bioserve India (P) Limited

DEAL BRIEF

QPS Holdings LLC ("QPS"), a US based contract research organisation focussed on bioanalysis, drug metabolism & pharmacokinetics, translational medicine, toxicology, early stage clinical and late stage clinical research, through its subsidiary XDD Acquisition B.V. acquired a controlling stake in Bioserve Clinical Research Private Limited ("Bioserve"), now known as QPS Bioserve India (P) Limited.

Bioserve is a private company in India and is engaged in the business of, inter alia, clinical trials and offers early stage capabilities in high end bioavailability and bioequivalence (BA/BE) and toxicology studies.

OUR ROLE

We, at Nishith Desai Associates, acted as Indian legal and tax counsel to QPS for this acquisition.

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.

Deal Corner

May 01, 2011

QPS Holdings LLC acquired a controlling stake in Bioserve Clinical Research Private Limited now known as QPS Bioserve India (P) Limited

DEAL BRIEF

QPS Holdings LLC ("QPS"), a US based contract research organisation focussed on bioanalysis, drug metabolism & pharmacokinetics, translational medicine, toxicology, early stage clinical and late stage clinical research, through its subsidiary XDD Acquisition B.V. acquired a controlling stake in Bioserve Clinical Research Private Limited ("Bioserve"), now known as QPS Bioserve India (P) Limited.

Bioserve is a private company in India and is engaged in the business of, inter alia, clinical trials and offers early stage capabilities in high end bioavailability and bioequivalence (BA/BE) and toxicology studies.

OUR ROLE

We, at Nishith Desai Associates, acted as Indian legal and tax counsel to QPS for this acquisition.

Disclaimer

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.